The ischemic environment drives microglia and macrophage function.
Stefano Fumagalli,Stefano Fumagalli,Carlo Perego,Francesca Pischiutta,Elisa R. Zanier,Maria Grazia De Simoni +5 more
Reads0
Chats0
TLDR
The selective responses of microglia and macrophages to hypoxia after stroke are discussed and relevant markers are reviewed with the aim of defining the different subpopulations of myeloid cells that are recruited to the injured site.Abstract:
Cells of myeloid origin, such as microglia and macrophages, act at the crossroads of several inflammatory mechanisms during pathophysiology. Besides pro-inflammatory activity (M1 polarization), myeloid cells acquire protective functions (M2) and participate in the neuroprotective innate mechanisms after brain injury. Experimental research is making considerable efforts to understand the rules that regulate the balance between toxic and protective brain innate immunity. Environmental changes affect microglia/macrophage functions. Hypoxia can affect myeloid cell distribution, activity, and phenotype. With their intrinsic differences, microglia and macrophages respond differently to hypoxia, the former depending on ATP to activate and the latter switching to anaerobic metabolism and adapting to hypoxia. Myeloid cell functions include homeostasis control, damage-sensing activity, chemotaxis, and phagocytosis, all distinctive features of these cells. Specific markers and morphologies enable to recognize each functional state. To ensure homeostasis and activate when needed, microglia/macrophage physiology is finely tuned. Microglia are controlled by several neuron-derived components, including contact-dependent inhibitory signals and soluble molecules. Changes in this control can cause chronic activation or priming with specific functional consequences. Strategies, such as stem cell treatment, may enhance microglia protective polarization. This review presents data from the literature that has greatly advanced our understanding of myeloid cell action in brain injury. We discuss the selective responses of microglia and macrophages to hypoxia after stroke and review relevant markers with the aim of defining the different subpopulations of myeloid cells that are recruited to the injured site. We also cover the functional consequences of chronically active microglia and review pivotal works on microglia regulation that offer new therapeutic possibilities for acute brain injury.read more
Citations
More filters
Journal ArticleDOI
Microglia in Physiology and Disease
TL;DR: The diversity of microglia phenotypes and their responses in health, aging, and disease are described and treatment options that modulate microglial phenotypes are discussed.
Journal ArticleDOI
Modulators of microglial activation and polarization after intracerebral haemorrhage.
TL;DR: Key studies on modulators of microglial activation and polarization after ICH are summarized, including M1-like and M2-like microglia phenotype markers, transcription factors and key signalling pathways, and the evidence that therapeutic approaches aimed at modulating microglian function might mitigate ICH injury and improve brain repair is presented.
Journal ArticleDOI
Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
TL;DR: This review summarizes recent progress concerning the mechanisms involved in brain damage, repair and regeneration related to microglia/macrophage activation and phenotype transition after stroke and argues that future translational studies should be targeting multiple key regulating molecules to improve brain repair.
Journal ArticleDOI
The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.
TL;DR: New potential therapeutics need to interfere with these diabetic complications even before changes in the retina are diagnosed, to prevent neuronal apoptosis and blindness in patients.
Journal ArticleDOI
Inflammatory Disequilibrium in Stroke
TL;DR: The frontiers of current knowledge of innate and adaptive immune responses in the brain and how these responses together shape the course of ischemic stroke are explored.
References
More filters
Journal ArticleDOI
Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.
Ashley M. Fenn,John C. Gensel,Yan Huang,Phillip G. Popovich,Jonathan Lifshitz,Jonathan P. Godbout +5 more
TL;DR: These results implicate a primed and immune-reactive microglial population as a possible triggering mechanism for the development of depressive complications after TBI.
Journal ArticleDOI
Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells
Nicholas H. Varvel,Nicholas H. Varvel,Stefan A. Grathwohl,Stefan A. Grathwohl,Frank Baumann,Frank Baumann,Christian Liebig,Christian Liebig,Andrea Bosch,Andrea Bosch,Bianca Brawek,Dietmar Rudolf Thal,Israel F. Charo,Frank L. Heppner,Adriano Aguzzi,Olga Garaschuk,Richard M. Ransohoff,Mathias Jucker,Mathias Jucker +18 more
TL;DR: It is shown that microglia-depleted brain regions of CD11b-HSVTK transgenic mice are repopulated with new Iba-1-positive cells within 2 wk and engrafted myeloid cells expressed high levels of CD45 and CCR2 and appeared in a wave-like pattern frequently associated with blood vessels, suggesting the engrafted cells were peripheral monocytes.
Journal ArticleDOI
Deficient CX3CR1 Signaling Promotes Recovery after Mouse Spinal Cord Injury by Limiting the Recruitment and Activation of Ly6Clo/iNOS+ Macrophages
Dustin J. Donnelly,Erin E. Longbrake,Todd Shawler,Kristina A. Kigerl,Wenmin Lai,C. Amy Tovar,Richard M. Ransohoff,Phillip G. Popovich +7 more
TL;DR: Blockade of CX3CR1 signaling represents a selective anti-inflammatory therapy that is able to promote neuroprotection, in part by reducing inflammatory signaling in microglia and MDMs and recruitment of a novel monocyte subset.
Journal ArticleDOI
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
Mibel Pabon,Adam D. Bachstetter,Charles Hudson,Carmelina Gemma,Carmelina Gemma,Paula C. Bickford,Paula C. Bickford +6 more
TL;DR: It is demonstrated that CX3CL1 plays a neuroprotective role in 6-OHDA-induced dopaminergic lesion and it might be an effective therapeutic target for many neurodegenerative diseases, including Parkinson disease and Alzheimer disease, where inflammation plays an important role.
Journal ArticleDOI
Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages
Alessandra A. Filardy,Dayana R. Pires,Marise P. Nunes,Christina Maeda Takiya,Celio Geraldo Freire-de-Lima,Flávia L. Ribeiro-Gomes,George A. DosReis +6 more
TL;DR: It is suggested that macrophage differentiation to a regulatory phenotype plays a role in resolution of inflammation but could contribute to increased humoral Ab responses and parasite persistence in the infected host.